PRESS RELEASE published on 06/17/2025 at 18:00, 9 months 8 days ago Amoéba takes another decisive step forward with the final approval of its biocontrol active substance by the European Commission Amoéba receives final approval from European Commission for its biocontrol active substance, AXPERA, after successful validation process confirming low-risk profile AMOEBA European Commission Biocontrol AXPERA Low-risk
BRIEF published on 06/03/2025 at 17:50, 9 months 22 days ago Amoéba and Koppert enter into a distribution agreement for an innovative biofungicide Innovation Sustainable Agriculture Distribution Biofungicide Biopesticide
PRESS RELEASE published on 06/03/2025 at 17:45, 9 months 22 days ago Koppert and Amoéba sign major distribution agreement for innovative biofungicide solution Koppert and Amoéba sign commercial agreement for innovative biofungicide solution, expanding distribution to 18 European countries and the United States. Collaboration aims for new biofungicide solutions and reinforces commitment to sustainable agriculture AMOEBA Sustainable Agriculture Commercial Agreement Biofungicide Koppert
BRIEF published on 05/22/2025 at 18:05, 10 months 3 days ago Amoéba: General Meeting scheduled for June 26, 2025 AMOEBA General Assembly Electronic Voting GreenTech Chassieu
PRESS RELEASE published on 05/22/2025 at 18:00, 10 months 3 days ago Amoéba: Ordinary and Extraordinary General Meeting of 26 June 2025 Amoéba announces Ordinary and Extraordinary General Meeting on 26 June 2025. Shareholders invited to attend. Agenda and resolutions available online. Electronic voting details provided AMOEBA Shareholders General Meeting Electronic Voting Biological Solutions
BRIEF published on 05/21/2025 at 18:05, 10 months 4 days ago Unanimous green light for Amoéba's active substance in Europe AMOEBA Food Safety Biocontrol European Union AXPERA
PRESS RELEASE published on 05/21/2025 at 18:00, 10 months 4 days ago A new milestone towards the market launch of AXPERA: EU Member States unanimously vote in favour of the approval of Amoéba's biocontrol active substance Amoéba receives unanimous approval from EU Member States for low-risk biocontrol substance based on amoebae lysate, a milestone for AXPERA solution market launch in Europe from 2026 AMOEBA Biocontrol EU Approval AXPERA Low-risk Substance
BRIEF published on 05/20/2025 at 19:05, 10 months 5 days ago Amoéba Strengthens its Board of Directors with Charlotte Franceries AMOEBA Board Of Directors GreenTech Cosmetic Charlotte Franceries
PRESS RELEASE published on 05/20/2025 at 19:00, 10 months 5 days ago Amoéba announces the nomination of Charlotte Franceries, a leading figure in the cosmetics and communications industry, to its Board of Directors Amoéba announces the proposed appointment of Charlotte Franceries as a member of its Board of Directors, bringing extensive expertise from the cosmetics industry AMOEBA Board Of Directors Appointment Cosmetics Industry Charlotte Franceries
BRIEF published on 05/12/2025 at 18:05, 10 months 13 days ago Amoéba and Koppert in final phase before the launch of AXPERA Biocontrol Agricultural Innovation Authorizations AXPERA Launch Amoéba Koppert
Published on 03/26/2026 at 04:55, 2 hours 17 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 6 hours 32 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 6 hours 42 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 11 hours 57 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 17 hours 42 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/26/2026 at 07:07, 4 minutes ago Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
Published on 03/26/2026 at 07:05, 7 minutes ago Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Published on 03/26/2026 at 07:05, 7 minutes ago EDAG Group: Market uncertainty and delayed awarding of projects shape FY 2025 – Strategic measures accelerated to restore sustainable growth and competitiveness
Published on 03/26/2026 at 07:00, 12 minutes ago WashTec AG: New record revenue of €498.6m with further increase in EBIT margin to 9.8% - at con-stant exchange rates revenue exceeds €500m for the first time
Published on 03/25/2026 at 18:31, 12 hours 41 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 13 hours 27 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting